193 related articles for article (PubMed ID: 11470272)
1. Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient.
Penzel R; Uhl J; Kopitz J; Beck M; Otto HF; Cantz M
FEBS Lett; 2001 Jul; 501(2-3):135-8. PubMed ID: 11470272
[TBL] [Abstract][Full Text] [Related]
2. Identification of a CTL4/Neu1 fusion transcript in a sialidosis patient.
Uhl J; Penzel R; Sergi C; Kopitz J; Otto HF; Cantz M
FEBS Lett; 2002 Jun; 521(1-3):19-23. PubMed ID: 12067718
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex.
Lukong KE; Elsliger MA; Chang Y; Richard C; Thomas G; Carey W; Tylki-Szymanska A; Czartoryska B; Buchholz T; Criado GR; Palmeri S; Pshezhetsky AV
Hum Mol Genet; 2000 Apr; 9(7):1075-85. PubMed ID: 10767332
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
Kwak JE; Son MY; Son YS; Son MJ; Cho YS
Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis and fetal pathology in a Turkish family harboring a novel nonsense mutation in the lysosomal alpha-N-acetyl-neuraminidase (sialidase) gene.
Sergi C; Penzel R; Uhl J; Zoubaa S; Dietrich H; Decker N; Rieger P; Kopitz J; Otto HF; Kiessling M; Cantz M
Hum Genet; 2001 Oct; 109(4):421-8. PubMed ID: 11702224
[TBL] [Abstract][Full Text] [Related]
6. Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis.
Bonten EJ; Arts WF; Beck M; Covanis A; Donati MA; Parini R; Zammarchi E; d'Azzo A
Hum Mol Genet; 2000 Nov; 9(18):2715-25. PubMed ID: 11063730
[TBL] [Abstract][Full Text] [Related]
7. Molecular pathology of NEU1 gene in sialidosis.
Seyrantepe V; Poupetova H; Froissart R; Zabot MT; Maire I; Pshezhetsky AV
Hum Mutat; 2003 Nov; 22(5):343-52. PubMed ID: 14517945
[TBL] [Abstract][Full Text] [Related]
8. Five novel mutations in the lysosomal sialidase gene (NEU1) in type II sialidosis patients and assessment of their impact on enzyme activity and intracellular targeting using adenovirus-mediated expression.
Pattison S; Pankarican M; Rupar CA; Graham FL; Igdoura SA
Hum Mutat; 2004 Jan; 23(1):32-9. PubMed ID: 14695530
[TBL] [Abstract][Full Text] [Related]
9. Sialidosis presenting as severe nonimmune fetal hydrops is associated with two novel mutations in lysosomal alpha-neuraminidase.
Loren DJ; Campos Y; d'Azzo A; Wyble L; Grange DK; Gilbert-Barness E; White FV; Hamvas A
J Perinatol; 2005 Jul; 25(7):491-4. PubMed ID: 15908988
[TBL] [Abstract][Full Text] [Related]
10. Mutations in sialidosis impair sialidase binding to the lysosomal multienzyme complex.
Lukong KE; Landry K; Elsliger MA; Chang Y; Lefrancois S; Morales CR; Pshezhetsky AV
J Biol Chem; 2001 May; 276(20):17286-90. PubMed ID: 11279074
[TBL] [Abstract][Full Text] [Related]
11. Clinical variability of type II sialidosis by C808T mutation.
Rodríguez Criado G; Pshezhetsky AV; Rodríguez Becerra A; Gómez de Terreros I
Am J Med Genet A; 2003 Feb; 116A(4):368-71. PubMed ID: 12522793
[TBL] [Abstract][Full Text] [Related]
12. Intermittent enzyme replacement therapy with recombinant human β-galactosidase prevents neuraminidase 1 deficiency.
Luu AR; Wong C; Agrawal V; Wise N; Handyside B; Lo MJ; Pacheco G; Felix JB; Giaramita A; d'Azzo A; Vincelette J; Bullens S; Bunting S; Christianson TM; Hague CM; LeBowitz JH; Yogalingam G
J Biol Chem; 2020 Sep; 295(39):13556-13569. PubMed ID: 32727849
[TBL] [Abstract][Full Text] [Related]
13. Modeling Sialidosis with Neural Precursor Cells Derived from Patient-Derived Induced Pluripotent Stem Cells.
Seol B; Kim YD; Cho YS
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922276
[TBL] [Abstract][Full Text] [Related]
14. Elimination of abnormal sialylglycoproteins in fibroblasts with sialidosis and galactosialidosis by normal gene transfer and enzyme replacement.
Oheda Y; Kotani M; Murata M; Sakuraba H; Kadota Y; Tatano Y; Kuwahara J; Itoh K
Glycobiology; 2006 Apr; 16(4):271-80. PubMed ID: 16361247
[TBL] [Abstract][Full Text] [Related]
15. Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation.
Liu SP; Hsu YH; Huang CY; Ho MC; Cheng YC; Wen CH; Lu HE; Tsai CH; Shyu WC; Hsieh PCH
Stem Cell Res; 2018 Apr; 28():39-43. PubMed ID: 29414417
[TBL] [Abstract][Full Text] [Related]
16. Novel missense mutations in the human lysosomal sialidase gene in sialidosis patients and prediction of structural alterations of mutant enzymes.
Itoh K; Naganawa Y; Matsuzawa F; Aikawa S; Doi H; Sasagasako N; Yamada T; Kira J; Kobayashi T; Pshezhetsky AV; Sakuraba H
J Hum Genet; 2002; 47(1):29-37. PubMed ID: 11829139
[TBL] [Abstract][Full Text] [Related]
17. Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice.
de Geest N; Bonten E; Mann L; de Sousa-Hitzler J; Hahn C; d'Azzo A
Hum Mol Genet; 2002 Jun; 11(12):1455-64. PubMed ID: 12023988
[TBL] [Abstract][Full Text] [Related]
18. Cloning, expression and chromosomal mapping of human lysosomal sialidase and characterization of mutations in sialidosis.
Pshezhetsky AV; Richard C; Michaud L; Igdoura S; Wang S; Elsliger MA; Qu J; Leclerc D; Gravel R; Dallaire L; Potier M
Nat Genet; 1997 Mar; 15(3):316-20. PubMed ID: 9054950
[TBL] [Abstract][Full Text] [Related]
19. Neu4, a novel human lysosomal lumen sialidase, confers normal phenotype to sialidosis and galactosialidosis cells.
Seyrantepe V; Landry K; Trudel S; Hassan JA; Morales CR; Pshezhetsky AV
J Biol Chem; 2004 Aug; 279(35):37021-9. PubMed ID: 15213228
[TBL] [Abstract][Full Text] [Related]
20. Lysosomal sialidase NEU1, its intracellular properties, deficiency, and use as a therapeutic agent.
Itoh K; Tsukimoto J
Glycoconj J; 2023 Dec; 40(6):611-619. PubMed ID: 38147151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
